Comparative Pharmacology
Head-to-head clinical analysis: AMPICILLIN TRIHYDRATE versus PENICILLIN.
Head-to-head clinical analysis: AMPICILLIN TRIHYDRATE versus PENICILLIN.
AMPICILLIN TRIHYDRATE vs PENICILLIN
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), inhibiting transpeptidation and autolysin activity.
Inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), inhibiting transpeptidation and autolysin activation, leading to cell lysis.
250-500 mg PO q6h or 1-2 g IV/IM q4-6h; up to 12 g/day IV for severe infections.
Penicillin G: 2-4 million units IV every 4-6 hours; Penicillin V: 250-500 mg orally every 6 hours for mild to moderate infections.
None Documented
None Documented
Terminal elimination half-life 1-1.8 hours; prolonged in renal impairment (up to 10-20 hours in anuria)
Clinical Note
moderateBenzylpenicillin + Teriflunomide
"The serum concentration of Teriflunomide can be increased when it is combined with Benzylpenicillin."
Clinical Note
moderateBenzylpenicillin + Acemetacin
"Benzylpenicillin may decrease the excretion rate of Acemetacin which could result in a higher serum level."
Clinical Note
moderateProcaine benzylpenicillin + Acemetacin
"Procaine benzylpenicillin may decrease the excretion rate of Acemetacin which could result in a higher serum level."
Clinical Note
moderate0.5-1.0 hours in normal renal function; prolonged to 7-10 hours in anuria. Dose adjustment required in renal impairment.
Renal: 75-90% unchanged; biliary: small amount; fecal: negligible
Primarily renal (60-80% unchanged via glomerular filtration and tubular secretion); biliary/fecal excretion accounts for 10-20%.
Category A/B
Category C
Penicillin Antibiotic
Penicillin Antibiotic
Phenoxymethylpenicillin + Acemetacin
"Phenoxymethylpenicillin may decrease the excretion rate of Acemetacin which could result in a higher serum level."